EDAP TMS SA(FOCL)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,822 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in FOCL
Events flagged as statistical outliers against FOCL's own multi-year baseline — not fixed dollar thresholds.
- Score shock2026-08-16
FOCL quality score dropped 31 points (48→16) on a new filing
View source filing → - Insider cluster2026-08-14
8 insiders bought $551,000 of FOCL in 30 days — 16.0σ above this company's 2-year norm
View source filing →
FOCL Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for EDAP TMS SA (FOCL), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FOCL at 17.8/100 on a 32-signal composite quality model, placing it at rank #2,822 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (2.5) and balance sheet strength (3.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), EDAP TMS SA reports quarterly revenue of $13.2M, net income of $-14.5M. Top institutional holders of FOCL by reported 13-F value include Soleus Capital Management, L.P., MORGAN STANLEY, Rock Springs Capital Management, based on the most recent SEC filings. FOCL trades on the Nasdaq exchange and files with the SEC under CIK 1041934. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FOCL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for EDAP TMS SA directly from SEC EDGAR. EDAP TMS SA's 13F Pro composite quality score has ranged between 16 and 47 since 2026, currently 17.8 — a stable long-term trajectory across 19 quarterly and live scoring snapshots.
Revenue
Q2 2026
$13.2M
Net Income
Q2 2026
$-14.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+1.6% YoYNet Income
-42.1% YoYOperating Income
-11.1% YoYEPS (Diluted)
-41.8% YoYTotal Assets
-11.6% YoYTotal Debt
+95.0% YoYOp. Cash Flow
-11.6% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $70.5M +1.6% | $69.4M +14.8% | $60.4M +9.6% | $55.1M +25.1% | $44.1M +5.8% | $41.7M |
| Net Income | $-29.2M -42.1% | $-20.6M +2.8% | $-21.2M -622.0% | $-2.9M -519.1% | $699.9K +141.1% | $-1.7M |
| Operating Income | $-24.7M -11.1% | $-22.2M -12.2% | $-19.8M -365.4% | $-4.3M -164.1% | $-1.6M -699.3% | $269.0K |
| EPS (Diluted) | $-0.78 -41.8% | $-0.55 +3.5% | $-0.57 -533.3% | $-0.09 -550.0% | $0.02 +133.3% | $-0.06 |
| Total Assets | $79.0M -11.6% | $89.4M -2.3% | $91.5M -9.5% | $101.1M +30.9% | $77.2M +39.9% | $55.2M |
| Total Debt | $26.1M +95.0% | $13.4M +77.0% | $7.6M -12.3% | $8.6M +1.6% | $8.5M -33.8% | $12.8M |
| Operating Cash Flow | $-16.4M -11.6% | $-14.7M -0.2% | $-14.7M -385.4% | $-3.0M -168.0% | $4.4M +124.8% | $2.0M |
Get alerted when FOCL's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for EDAP TMS SA including:
Top Institutional Holders of FOCL
Soleus Capital Management, L.P.
$37.9M7,309,254 shMORGAN STANLEY
$17.3M3,336,872 shRock Springs Capital Management LP
$7.2M1,386,000 shFLAX POND CAPITAL, LLC
$2.9M789,446 shBruce & Co., Inc.
$2.3M438,652 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$2.0M392,200 shJANE STREET GROUP, LLC
$1.4M271,500 shCITADEL ADVISORS LLC
$876.5K169,200 shParkman Healthcare Partners LLC
$802.0K154,832 shESSEX INVESTMENT MANAGEMENT CO LLC
$756.3K146,005 sh
| Fund | Value | Shares |
|---|---|---|
| Soleus Capital Management, L.P. | $37.9M | 7,309,254 |
| MORGAN STANLEY | $17.3M | 3,336,872 |
| Rock Springs Capital Management LP | $7.2M | 1,386,000 |
| FLAX POND CAPITAL, LLC | $2.9M | 789,446 |
| Bruce & Co., Inc. | $2.3M | 438,652 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.0M | 392,200 |
| JANE STREET GROUP, LLC | $1.4M | 271,500 |
| CITADEL ADVISORS LLC | $876.5K | 169,200 |
| Parkman Healthcare Partners LLC | $802.0K | 154,832 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $756.3K | 146,005 |
Companies Similar to FOCL
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Organogenesis Holdings Inc.
DarioHealth Corp.
Nanobiotix S.A.
MANNATECH INC
RETRACTABLE TECHNOLOGIES INC
SINOVAC BIOTECH LTD
Intercure Ltd.
Sensus Healthcare, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put FOCL on your watchlist
Track score changes the day EDAP TMS SA files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is FOCL a good stock to buy?
13F Pro's AI-powered analysis of EDAP TMS SA (FOCL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FOCL are available on the FOCL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. FOCL is classified as a small company.
Which hedge funds own FOCL?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FOCL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of EDAP TMS SA's investment landscape.